The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
BODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
Pochon, S. (2005) · American Journal of Cancer · doi:10.2165/00024669-200504040-00008 · Cited by 1,424
Crawford, J., Ozer, H., Stoller, R., Johnson, D., Lyman, G., Tabbara, I., Kris, M., Grous, J., Picozzi, V., Rausch, G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107183250305 · Cited by 1,390
Self-citationKlastersky, J., Paesmans, M., Rubenstein, E. B., Boyer, M., Elting, L., Feld, R., Gallagher, J., Herrstedt, J., Rapoport, B., Rolston, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3038 · Cited by 1,171
Kelly, K., Crowley, J., Bunn, P. A., Presant, C. A., Grevstad, P. K., Moinpour, C. M., Ramsey, S. D., Wozniak, A. J., Weiss, G. R., Moore, D. F., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3210 · Cited by 1,123
du Bois, A. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg036 · Cited by 1,113
O’Shaughnessy, J., Miles, D., Vukelja, S., Moiseyenko, V., Ayoub, J.-P., Cervantes, G., Fumoleau, P., Jones, S., Lui, W.-Y., Mauriac, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.002 · Cited by 1,081
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
Ozer, H., Armitage, J. O., Bennett, C. L., Crawford, J., Demetri, G. D., Pizzo, P. A., Schiffer, C. A., Smith, T. J., Somlo, G., Wade, J. C., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3558 · Cited by 1,044
Self-citationvon Pawel, J., Schiller, J. H., Shepherd, F. A., Fields, S. Z., Kleisbauer, J. P., Chrysson, N. G., Stewart, D. J., Clark, P. I., Palmer, M. C., Depierre, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.658 · Cited by 968
Fossella, F., Pereira, J. R., von Pawel, J., Pluzanska, A., Gorbounova, V., Kaukel, E., Mattson, K. V., Ramlau, R., Szczęsna, A., Fidias, P., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.046 · Cited by 939
Scagliotti, G. V., De Marinis, F., Rinaldi, M., Crinò, L., Gridelli, C., Ricci, S., Matano, E., Boni, C., Marangolo, M., Failla, G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.068 · Cited by 889
Chemotherapy‐induced neutropenia: Risks, consequences, and new directions for its management
Crawford, J., Dale, D. C., & Lyman, G. H. (2004) · Cancer · doi:10.1002/cncr.11882 · Cited by 882
Self-citationDiehl, V., Franklin, J., Pfreundschuh, M., Lathan, B., Paulus, U., Hasenclever, D., Tesch, H., Herrmann, R., Dörken, B., Müller-Hermelink, H.-K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022473 · Cited by 838
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Dionisi, M. S., Martinelli, G., Allione, B., D'Antonio, D., Buelli, M., Nosari, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044097 · Cited by 648
Sternberg, C. N., de Mulder, P. H. M., Schornagel, J. H., Théodore, C., Fossa, S. D., van Oosterom, A. T., Witjes, F., Spina, M., van Groeningen, C. J., de Balincourt, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2638 · Cited by 628
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Green, M. D., Koelbl, H., Baselga, J., Galid, A., Guillem, V., Gascon, P., Siena, S., Lalisang, R. I., Samonigg, H., Clemens, M. R., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg019 · Cited by 586
Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer
Budman, D. R., Berry, D. A., Cirrincione, C. T., Henderson, Wood, W. C., Weiss, R. B., Ferree, C. R., Muss, H. B., Green, M. R., Norton, L., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1205 · Cited by 577
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
Wood, W. C., Budman, D. R., Korzun, A. H., Cooper, M. R., Younger, J., Hart, R. D., Moore, A., Ellerton, J. A., Norton, L., Ferree, C. R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301801 · Cited by 577
Fleming, G. F., Brunetto, V. L., Cella, D., Look, K. Y., Reid, G. C., Munkarah, A. R., Kline, R., Burger, R. A., Goodman, A., & Burks, R. T. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.184 · Cited by 565
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
(1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310226 · Cited by 556
Wozniak, A. J., Crowley, J. J., Balcerzak, S. P., Weiss, G. R., Spiridonidis, C. H., Baker, L. H., Albain, K. S., Kelly, K., Taylor, S. A., Gandara, D. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2459 · Cited by 555
Gianni, L., Munzone, E., Capri, G., Fulfaro, F., Tarenzi, E., Villani, F., Spreafico, C., Laffranchi, A., Caraceni, A., & Martini, C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2688 · Cited by 553
Trillet-Lenoir, V., Green, J., Manegold, C., Von Pawel, J., Gatzemeier, U., Lebeau, B., Depierre, A., Johnson, P., Decoster, G., Tomita, D., et al. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90376-q · Cited by 543
Holmes, F. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.727 · Cited by 537
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
Gafter-Gvili, A., Fraser, A., Paul, M., & Leibovici, L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00008 · Cited by 499
Vogel, C. L., Wojtukiewicz, M. Z., Carroll, R. R., Tjulandin, S. A., Barajas-Figueroa, L. J., Wiens, B. L., Neumann, T. A., & Schwartzberg, L. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.102 · Cited by 482
Cardenal, F., López-Cabrerizo, M. P., Antón, A., Alberola, V., Massuti, B., Carrato, A., Barneto, I., Lomas, M., García, M., Lianes, P., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.12 · Cited by 471
Lyman, G. H., Dale, D. C., & Crawford, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.002 · Cited by 464
Self-citationPettengell, R., Gurney, H., Radford, J., Deakin, D., James, R., Wilkinson, P., Kane, K., Bentley, J., & Crowther, D. (1992) · Blood · doi:10.1182/blood.v80.6.1430.1430 · Cited by 440
Self-citationKwak, L. W., Halpern, J., Olshen, R. A., & Horning, S. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.6.963 · Cited by 431
Velasquez, W. S., McLaughlin, P., Tucker, S., Hagemeister, F. B., Swan, F., Rodriguez, M. A., Romaguera, J., Rubenstein, E., & Cabanillas, F. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1169 · Cited by 430
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., Stuart, N., Rea, D., Bower, M., Fernando, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050078 · Cited by 422
von Minckwitz, G., Raab, G., Caputo, A., Schütte, M., Hilfrich, J., Blohmer, J. U., Gerber, B., Costa, S. D., Merkle, E., Eidtmann, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.078 · Cited by 417
Cutsem, E. V., Hoff, P. M., Harper, P., Bukowski, R. M., Cunningham, D., Dufour, P., Graeven, U., Lokich, J., Madajewicz, S., Maroun, J. A., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601676 · Cited by 401
Nabholtz, J.-M., Falkson, C., Campos, D., Szanto, J., Martin, M., Chan, S., Pienkowski, T., Zaluski, J., Pinter, T., Krzakowski, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.040 · Cited by 384
Creemers, G. J., Bolis, G., Gore, M., Scarfone, G., Lacave, A. J., Guastalla, J. P., Despax, R., Favalli, G., Kreinberg, R., Van Belle, S., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3056 · Cited by 377
Tannock, I. F., Boyd, N. F., DeBoer, G., Erlichman, C., Fine, S., Larocque, G., Mayers, C., Perrault, D., & Sutherland, H. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.9.1377 · Cited by 348
Risk Models for Predicting Chemotherapy-Induced Neutropenia
Lyman, G. H., Lyman, C. H., Agboola, O., & Anc Study Group (2005) · The Oncologist · doi:10.1634/theoncologist.10-6-427 · Cited by 336
Self-citationHorning, S. J., Hoppe, R. T., Breslin, S., Bartlett, N. L., Brown, B. W., & Rosenberg, S. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.630 · Cited by 324
Bookman, M. A., Malmström, H., Bolis, G., Gordon, A., Lissoni, A., Krebs, J. B., & Fields, S. Z. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3345 · Cited by 321
Lyman, G. H., Dale, D. C., Friedberg, J., Crawford, J., & Fisher, R. I. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.213 · Cited by 315
Self-citationClark, O. A. C., Lyman, G. H., Castro, A. A., Clark, L. G. O., & Djulbegovic, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.645 · Cited by 310
Self-citationJassem, J., Pieńkowski, T., Płuzańska, A., Jelic, S., Gorbunova, V., Mrsic-Krmpotic, Z., Berzins, J., Nagykalnai, T., Wigler, N., Renard, J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1707 · Cited by 308
Fuchs, C. S., Moore, M. R., Harker, G., Villa, L., Rinaldi, D., & Hecht, J. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.058 · Cited by 296
Holmes, F. A., Jones, S. E., O’Shaughnessy, J., Vukelja, S., George, T., Savin, M., Richards, D., Glaspy, J., Meza, L., Cohen, G., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf130 · Cited by 291
The importance of dose intensity in the outcome of chemotherapy.
Wm, H. (1988) · PubMed · Cited by 256
By the French Adjuvant Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.602 · Cited by 252
Lyman, G. H., Morrison, V. A., Dale, D. C., Crawford, J., Delgado, D. J., & Fridman, M. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000119262 · Cited by 224
Self-citationTherasse, P., Mauriac, L., Welnicka-Jaskiewicz, M., Bruning, P., Cufer, T., Bonnefoi, H., Tomiak, E., Pritchard, K. I., Hamilton, A., & Piccart, M. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.135 · Cited by 224
Thatcher, N., Girling, D. J., Hopwood, P., Sambrook, R. J., Qian, W., Stephens, R. J., & for the Medical Research Council Lung Cancer Working Party (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.395 · Cited by 224
Lyman, G. H., Kuderer, N. M., & Djulbegovic, B. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01036-7 · Cited by 221
Self-citationRose, P. G., Blessing, J. A., Gershenson, D. M., & McGehee, R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2676 · Cited by 206
Vose, J. M., Crump, M., Lazarus, H., Emmanouilides, C., Schenkein, D., Moore, J., Frankel, S., Flinn, I., Lovelace, W., Hackett, J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.040 · Cited by 187
Timmer-Bonte, J. N., de Boo, T. M., Smit, H. J., Biesma, B., Wilschut, F. A., Cheragwandi, S. A., Termeer, A., Hensing, C. A., Akkermans, J., Adang, E. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7955 · Cited by 185
Self-citationCrawford, J., Allen, J., Armitage, J., Blayney, D. W., Cataland, S. R., Heaney, M. L., Htoy, S., Hudock, S., Kloth, D. D., Kuter, D. J., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0075 · Cited by 177
Self-citationGarcia-Carbonero, R., Mayordomo, J. I., Tornamira, M. V., Lopez-Brea, M., Rueda, A., Guillem, V., Arcediano, A., Yubero, A., Ribera, F., Gomez, C., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.31 · Cited by 177
Repetto, L., Biganzoli, L., Koehne, C. H., Luebbe, A. S., Soubeyran, P., Tjan-Heijnen, V. C. G., & Aapro, M. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00662-2 · Cited by 174
Self-citationLepage, E., Gisselbrecht, C., Haioun, C., Sebban, C., Tilly, H., Bosly, A., Morel, P., Herbrecht, R., Reyes, F., & Coiffier, B. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058619 · Cited by 174
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
Bohlius, J., Herbst, C., Reiser, M., Schwarzer, G., & Engert, A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003189.pub4 · Cited by 157
Self-citationMaindrault‐Gœbel, F., de Gramont, A., Louvet, C., André, T., Carola, É., Mabro, M., Artru, P., Gilles-Amar, V., Lotz, J., Izrael, V., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00068-5 · Cited by 153
Vaughn, D. J., Malkowicz, S. B., Zoltick, B. H., Mick, R., Ramchandani, P., Holroyde, C. P., Armstead, B., Fox, K. R., & Wein, A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.255 · Cited by 149
Steward, W. P., von Pawel, J., Gatzemeier, U., Woll, P. J., Thatcher, N., Koschel, G., Clancy, L., Verweij, J., de Wit, R., Pfeifer, W., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.642 · Cited by 145
Mayers, C., Panzarella, T., & Tannock, I. F. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12<2246::aid-cncr1255>3.0.co;2-4 · Cited by 132
Misset, J. L., Dieras, V. C., Gruia, G., Bourgeois, H. P., Cvitkovic, E., Kalla, S., Bozec, L., Beuzeboc, P., Jasmin, C., Aussel, J. P., et al. (1999) · Annals of Oncology · doi:10.1023/a:1026418831238 · Cited by 128
Alba, E., Martín, M., Ramos, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.125 · Cited by 128
Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma
Verschraegen, C. F., Sittisomwong, T., Kudelka, A. P., Guedes, E. D. P., Steger, M., Nelson-Taylor, T., Vincent, M., Rogers, R. W., Atkinson, E. N., & Kavanagh, J. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2733 · Cited by 126
Woll, P. J., Hodgetts, J., Lomax, L., Bildet, F., Cour-Chabernaud, V., & Thatcher, N. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.652 · Cited by 125
Tjan‐Heijnen, V. C. G., Postmus, P. E., Ardizzoni, A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1012545507920 · Cited by 113
Self-citationPapaldo, P., Lopez, M., Marolla, P., Cortesi, E., Antimi, M., Terzoli, E., Vici, P., Barone, C. A., Ferretti, G., Cosimo, S. D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.099 · Cited by 96
Vellenga, E., Groot, C. A. U.-D., de Wit, R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.619 · Cited by 96
van de Wetering, M. D., de Witte, M. A., Kremer, L. C. M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.006 · Cited by 94
Shin, D. M., Khuri, F. R., Glisson, B. S., Ginsberg, L. E., Papadimitrakopoulou, V., Clayman, G. L., Lee, J. J., Ang, K. K., Lippman, S. M., & Hong, W. K. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1316::aid-cncr1134>3.0.co;2-0 · Cited by 78
Ardizzoni, A., Manegold, C., Debruyne, C., Gaafar, R. M., Buchholz, E., Smit, E. F., LIANES, P., ten Velde, G. P. M., Bosquée, L., Legrand, C., et al. (2003) · PubMed · Cited by 72
Lyman, G. H., & Kuderer, N. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.01.001 · Cited by 71
Self-citationOnce-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia
Crawford, J. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00314-2 · Cited by 70
Self-citationStathopoulos, G. P., Veslemes, M., Georgatou, N., Antoniou, D., Giamboudakis, P., Katis, K., Tsavdaridis, D., Rigatos, S. K., Dimitroulis, J., Bastani, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh260 · Cited by 60
Pfreundschuh, M. G., Kloess, M., Schmits, R., et al. (2005) · Blood · doi:10.1182/blood.v106.11.13.13 · Cited by 56
Ravaud, A., Chevreau, C., Cany, L., Houyau, P., Dohollou, N., Roche, H. H., Soubeyran, P., Bonichon, F., Mihura, J., Eghbali, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2930 · Cited by 51
Stathopoulos, G. P., Rigatos, S. K., Dimopoulos, M. A., Giannakakis, T., Foutzilas, G., Kouroussis, C., Janinis, D., Aravantinos, G., Androulakis, N., Agelaki, S., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg109 · Cited by 46
Edelman, M. J., Chansky, K., Gaspar, L. E., Leigh, B. R., Weiss, G. R., Taylor, S. A., Crowley, J. J., Livingston, R. B., & Gandara, D. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.070 · Cited by 46
Schoemaker, N. E., Kuppens, I. E. L. M., Moiseyenko, V. M., Glimelius, B. L. G., Kjær, M., Starkhammer, H., Richel, D. J., Smaaland, R., Bertelsen, K., Poulsen, J. P., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602172 · Cited by 35
Lenograstim as Support for ACE Chemotherapy of Small-Cell Lung Cancer
Gatzemeier, U., Kleisbauer, J. P., Drings, P., Kaukel, E., Samaras, N., Melo, M. J., Cardenal, F., Robinet, G., Snijder, R. J. R., von Pawel, J., et al. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200008000-00017 · Cited by 35
Mabro, M., Louvet, C., André, T., Carola, É., Gilles-Amar, V., Artru, P., KRULIK, M., & de Gramont, A. (2003) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000020581.59835.7a · Cited by 30
Wolff, D. A., Crawford, J., Dale, D. C., Poniewierski, M. S., & Lyman, G. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.6125 · Cited by 14
Self-citationSzucs, T. D., Léonard, R., Pettengell, R., Paridaens, R., Jackisch, C., Constenla, M., Bosly, A., & Schwenkglenks, M. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.619 · Cited by 13
Self-citation
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Stewart, F. A., Akleyev, A. V., Hauer-Jensen, M., Hendry, J. H., Kleiman, N. J., MacVittie, T. J., Aleman, B. M., Edgar, A. B., Mabuchi, K., Muirhead, C. R., et al. (2012) · Annals of the ICRP · doi:10.1016/j.icrp.2012.02.001 · Cited by 1,604
Aapro, M. S., Bohlius, J., Cameron, D. A., Lago, L. D., Donnelly, J. P., Kearney, N., Lyman, G. H., Pettengell, R., Tjan-Heijnen, V. C., Walewski, J., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.013 · Cited by 1,090
Self-citationKuderer, N. M., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8823 · Cited by 720
Self-citationFreifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 704
Metadata
- Authors
- Aapro, M. S., Cameron, D. A., Pettengell, R., Bohlius, J., Crawford, J., Ellis, M., Kearney, N., Lyman, G. H., Tjan-Heijnen, V. C., Walewski, J., Weber, D. C., & Zielinski, C.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 42
- Issue
- 15
- Pages
- 2433-2453
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2169203358
- Cited by
- 539
- References
- 96
- FWCI
- 25.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.